A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes-Reference-Cited by-同舟云学术

A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes

Published:2017-08-16 Issue:19 Volume:1 Page:1505-1516
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Yao Chi-Yuan¹²³,Chen Ching-Hsuan⁴,Huang Huai-Hsuan¹,Hou Hsin-An¹,Lin Chien-Chin¹²³,Tseng Mei-Hsuan¹,Kao Chein-Jun¹,Lu Tzu-Pin⁴,Chou Wen-Chien¹²,Tien Hwei-Fang¹

Affiliation:

1. Division of Hematology, Department of Internal Medicine, and

2. Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan; and

3. Graduate Institute of Clinical Medicine, College of Medicine, and

4. Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan

Abstract

Key Points Through lncRNA profiling, we identified an MDS patient subset with distinct clinical and mutational patterns along with inferior outcomes. A concise yet powerful 4-lncRNA risk-scoring system was devised with the potential to improve current MDS risk stratification.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/1/19/1505/877920/advances008284.pdf

Reference87 articles.

1. Myelodysplastic syndromes;Tefferi;N Engl J Med,2009

2. Myelodysplastic syndromes;Adès;Lancet,2014

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Revised international prognostic scoring system for myelodysplastic syndromes;Greenberg;Blood,2012

5. How I treat patients with myelodysplastic syndromes;Stone;Blood,2009

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower‐risk myelodysplastic neoplasms;International Journal of Cancer;2024-01-05

2. The Role of Non-Coding RNAs in Myelodysplastic Neoplasms;Cancers;2023-09-30

3. LncRNA PCSK1N-202 regulates CD34 + hematopoietic cells proliferation in MDS patients via PIM2/HIF-1alpha;2023-07-31

4. Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes;International Journal of Molecular Sciences;2022-12-16

5. The Impact of Clonal Hierarchy and Heterogeneity on Phenotypic Manifestations of Myelodysplastic Neoplasms;Cancers;2022-11-19